These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 38432099)

  • 1. Thyroid dysfunction after immune checkpoint inhibitors in a single-centre UK pan-cancer cohort: A retrospective study.
    Kennedy OJ; Ali N; Lee R; Monaghan P; Adam S; Cooksley T; Lorigan P
    Eur J Cancer; 2024 May; 202():113949. PubMed ID: 38432099
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thyroid Immune-related Adverse Events Following Immune Checkpoint Inhibitor Treatment.
    Muir CA; Clifton-Bligh RJ; Long GV; Scolyer RA; Lo SN; Carlino MS; Tsang VHM; Menzies AM
    J Clin Endocrinol Metab; 2021 Aug; 106(9):e3704-e3713. PubMed ID: 33878162
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Combined Effect of Immune Checkpoint Inhibitors and Tyrosine Kinase Inhibitors on Thyroid Function.
    Tsai K; Ma H; Liang TZ; Xing Y; Chung S; Dorff T; Bell D; Lechner MG
    Thyroid; 2024 Feb; 34(2):158-166. PubMed ID: 38069567
    [No Abstract]   [Full Text] [Related]  

  • 4. Thyroid function abnormality induced by PD-1 inhibitors have a positive impact on survival in patients with non-small cell lung cancer.
    Zhou Y; Xia R; Xiao H; Pu D; Long Y; Ding Z; Liu J; Ma X
    Int Immunopharmacol; 2021 Feb; 91():107296. PubMed ID: 33360368
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changes in thyroid function and evolution of subclinical thyroid disease in older men.
    Tan SY; Chubb SAP; Flicker L; Almeida OP; Golledge J; Hankey GJ; Yeap BB
    Clin Endocrinol (Oxf); 2024 Feb; 100(2):170-180. PubMed ID: 38059618
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thyroid dysfunction after immune checkpoint inhibitor treatment in a single-center Chinese cohort: a retrospective study.
    Wu L; Xu Y; Wang X; Cheng X; Zhang Y; Wang Y; Fan X; Zhao H; Liu H; Chai X; Zhang L; Wang M; Li N; Pan H; Lian X
    Endocrine; 2023 Jul; 81(1):123-133. PubMed ID: 36867366
    [TBL] [Abstract][Full Text] [Related]  

  • 7. BASELINE TSH LEVEL IS ASSOCIATED WITH RISK OF ANTI-PD-1-INDUCED THYROID DYSFUNCTION.
    Pollack RM; Kagan M; Lotem M; Dresner-Pollak R
    Endocr Pract; 2019 Aug; 25(8):824-829. PubMed ID: 31013164
    [No Abstract]   [Full Text] [Related]  

  • 8. Subclinical thyroid dysfunction and fracture risk: a meta-analysis.
    Blum MR; Bauer DC; Collet TH; Fink HA; Cappola AR; da Costa BR; Wirth CD; Peeters RP; Åsvold BO; den Elzen WP; Luben RN; Imaizumi M; Bremner AP; Gogakos A; Eastell R; Kearney PM; Strotmeyer ES; Wallace ER; Hoff M; Ceresini G; Rivadeneira F; Uitterlinden AG; Stott DJ; Westendorp RG; Khaw KT; Langhammer A; Ferrucci L; Gussekloo J; Williams GR; Walsh JP; Jüni P; Aujesky D; Rodondi N;
    JAMA; 2015 May; 313(20):2055-65. PubMed ID: 26010634
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of abnormal thyrotropin concentrations measured by a sensitive assay in patients with type 2 diabetes mellitus.
    Celani MF; Bonati ME; Stucci N
    Diabetes Res; 1994; 27(1):15-25. PubMed ID: 7648793
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Higher baseline TSH levels predict early hypothyroidism during cancer immunotherapy.
    Luongo C; Morra R; Gambale C; Porcelli T; Sessa F; Matano E; Damiano V; Klain M; Schlumberger M; Salvatore D
    J Endocrinol Invest; 2021 Sep; 44(9):1927-1933. PubMed ID: 33576954
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of Thyroid Dysfunction With Cognitive Function: An Individual Participant Data Analysis.
    van Vliet NA; van Heemst D; Almeida OP; Åsvold BO; Aubert CE; Bae JB; Barnes LE; Bauer DC; Blauw GJ; Brayne C; Cappola AR; Ceresini G; Comijs HC; Dartigues JF; Degryse JM; Dullaart RPF; van Eersel MEA; den Elzen WPJ; Ferrucci L; Fink HA; Flicker L; Grabe HJ; Han JW; Helmer C; Huisman M; Ikram MA; Imaizumi M; de Jongh RT; Jukema JW; Kim KW; Kuller LH; Lopez OL; Mooijaart SP; Moon JH; Moutzouri E; Nauck M; Parle J; Peeters RP; Samuels MH; Schmidt CO; Schminke U; Slagboom PE; Stordal E; Vaes B; Völzke H; Westendorp RGJ; Yamada M; Yeap BB; Rodondi N; Gussekloo J; Trompet S;
    JAMA Intern Med; 2021 Nov; 181(11):1440-1450. PubMed ID: 34491268
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The association between subclinical thyroid dysfunction and dementia: The Health, Aging and Body Composition (Health ABC) Study.
    Aubert CE; Bauer DC; da Costa BR; Feller M; Rieben C; Simonsick EM; Yaffe K; Rodondi N;
    Clin Endocrinol (Oxf); 2017 Nov; 87(5):617-626. PubMed ID: 28850708
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Divergent prognostic effects of pre-existing and treatment-emergent thyroid dysfunction in patients treated with immune checkpoint inhibitors.
    von Itzstein MS; Gonugunta AS; Wang Y; Sheffield T; Lu R; Ali S; Fattah FJ; Xie D; Cai J; Xie Y; Gerber DE
    Cancer Immunol Immunother; 2022 Sep; 71(9):2169-2181. PubMed ID: 35072744
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incidence of thyroid dysfunction caused by immune checkpoint inhibitors combined with chemotherapy: A systematic review and meta-analysis.
    Yang P; Shen G; Zhang H; Zhang C; Li J; Zhao F; Li Z; Liu Z; Wang M; Zhao J; Zhao Y
    Int Immunopharmacol; 2024 May; 133():111961. PubMed ID: 38608442
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thyroid function and mortality in patients treated for hyperthyroidism.
    Franklyn JA; Sheppard MC; Maisonneuve P
    JAMA; 2005 Jul; 294(1):71-80. PubMed ID: 15998893
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PD-L1 Inhibitor-Induced Thyroiditis Is Associated with Better Overall Survival in Cancer Patients.
    Kotwal A; Kottschade L; Ryder M
    Thyroid; 2020 Feb; 30(2):177-184. PubMed ID: 31813343
    [No Abstract]   [Full Text] [Related]  

  • 17. Immune Checkpoint Inhibitor-induced Thyroid Disorders: A Single Center Experience.
    Patrizio A; Fallahi P; Antonelli A; Ferrari SM
    Curr Pharm Des; 2023; 29(4):295-299. PubMed ID: 35593347
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immune Checkpoint Inhibitor-related New-onset Thyroid Dysfunction: A Retrospective Analysis Using the US FDA Adverse Event Reporting System.
    Lu D; Yao J; Yuan G; Gao Y; Zhang J; Guo X
    Oncologist; 2022 Mar; 27(2):e126-e132. PubMed ID: 35641200
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Duration of thyroid dysfunction correlates with all-cause mortality. the OPENTHYRO Register Cohort.
    Laulund AS; Nybo M; Brix TH; Abrahamsen B; Jørgensen HL; Hegedüs L
    PLoS One; 2014; 9(10):e110437. PubMed ID: 25340819
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association between maternal thyroid function and risk of gestational hypertension and pre-eclampsia: a systematic review and individual-participant data meta-analysis.
    Toloza FJK; Derakhshan A; Männistö T; Bliddal S; Popova PV; Carty DM; Chen L; Taylor P; Mosso L; Oken E; Suvanto E; Itoh S; Kishi R; Bassols J; Auvinen J; López-Bermejo A; Brown SJ; Boucai L; Hisada A; Yoshinaga J; Shilova E; Grineva EN; Vrijkotte TGM; Sunyer J; Jiménez-Zabala A; Riaño-Galan I; Lopez-Espinosa MJ; Prokop LJ; Singh Ospina N; Brito JP; Rodriguez-Gutierrez R; Alexander EK; Chaker L; Pearce EN; Peeters RP; Feldt-Rasmussen U; Guxens M; Chatzi L; Delles C; Roeters van Lennep JE; Pop VJM; Lu X; Walsh JP; Nelson SM; Korevaar TIM; Maraka S
    Lancet Diabetes Endocrinol; 2022 Apr; 10(4):243-252. PubMed ID: 35255260
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.